Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.38 |
| ▸ | MEN1 | O00255 | 3/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | CNR1 | P21554 | 4/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | SELP | P16109 | 1/20 | 0.32 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.32 |
| ▸ | FAAH | O00519 | 1/20 | 0.32 |
| ▸ | KCNK3 | O14649 | 1/20 | 0.32 |
| ▸ | CNR2 | P34972 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.32 |
| ▸ | NAAA | Q02083 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29573839 | 0.88 | MEN1 (0.39) | ALDH1A1MEN1KMT2AUSP2 | |
| SCHEMBL2560023 | 0.84 | MMP1 (0.41) | ALDH1A1MEN1KMT2AMAPTKDM4E | |
| SCHEMBL8855259 | 0.81 | — | — | |
| SCHEMBL3298402 | 0.80 | PAOX (0.33) | ALDH1A1MEN1KMT2ACYP2C9CYP2C19 | |
| SCHEMBL11524825 | 0.80 | EPHX1 (0.48) | MEN1KMT2A | |
| SCHEMBL10910411 | 0.78 | TDP1 (0.35) | ALDH1A1MEN1KMT2A | |
| SCHEMBL7936208 | 0.78 | — | — | |
| SCHEMBL28318913 | 0.78 | KDM4E (0.49) | ALDH1A1MEN1KMT2AKDM4E | |
| SCHEMBL5175562 | 0.77 | ALOX15 (0.40) | ALDH1A1MEN1KMT2AUSP2MAPT | |
| SCHEMBL3293232 | 0.77 | PAOX (0.44) | MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11458083-B2 | Cosmetic and/or dermatological composition containing a merocyanine derivative comprising specific polar groups consisting of hydroxyl- and ether-functionalities | L'OREAL (FR) | 2022-10-04 | — | — | US | disclosed |
| CN-115137518-A | Storage stable dental adhesive kit for use with peroxide and hydroperoxide redox initiated composite materials | 义获嘉伟瓦登特公司 | 2022-10-04 | — | — | CN | disclosed |
| EP-2734180-B1 | COSMETIC AND/OR DERMATOLOGICAL COMPOSITION CONTAINING A MEROCYANINE DERIVATIVE COMPRISING SPECIFIC POLAR GROUPS CONSISTING OF HYDROXYL- AND ETHER-FUNCTIONALITIES | OREAL (FR) | 2021-03-31 | — | — | EP | disclosed |
| EP-2734499-B1 | MEROCYANINE DERIVATIVES | BASF SE (DE) | 2020-06-24 | — | — | EP | disclosed |
| US-9550730-B2 | Merocyanine derivatives | BASF SE (DE) | 2017-01-24 | — | — | US | disclosed |
| CN-102471632-B | Aqueous polymer dispersion as a binding agent for plasters and coating materials having improved fire behavior | BASF SE | 2014-12-03 | — | — | CN | disclosed |
| US-20140294743-A1 | COSMETIC AND/OR DERMATOLOGICAL COMPOSITION CONTAINING A MEROCYANINE DERIVATIVE COMPRISING SPECIFIC POLAR GROUPS CONSISTING OF HYDROXYL- AND ETHER-FUNCTIONALITIES | L'OREAL (FR) | 2014-10-02 | — | — | US | disclosed |
| US-20140150380-A1 | MEROCYANINE DERIVATIVES | BASF SE (DE) | 2014-06-05 | — | — | US | disclosed |
| EP-2734180-A2 | COSMETIC AND/OR DERMATOLOGICAL COMPOSITION CONTAINING A MEROCYANINE DERIVATIVE COMPRISING SPECIFIC POLAR GROUPS CONSISTING OF HYDROXYL- AND ETHER-FUNCTIONALITIES | L'OREAL (FR) | 2014-05-28 | — | — | EP | disclosed |
| EP-2734499-A1 | MEROCYANINE DERIVATIVES | BASF SE (DE) | 2014-05-28 | — | — | EP | disclosed |
| CN-102325797-B | Binder compositions comprising boric acid or boric acid salt | BASF SE | 2014-02-12 | — | — | CN | disclosed |
| CN-102037034-B | Polymer dispersions containing phosphorous polymers and emulsifiers | BASF SE | 2013-06-19 | — | — | CN | disclosed |
| WO-2013011480-A1 | MEROCYANINE DERIVATIVES | BASF SE (DE) | 2013-01-24 | — | — | WO | disclosed |
| WO-2013011094-A2 | COSMETIC AND/OR DERMATOLOGICAL COMPOSITION CONTAINING A MEROCYANINE DERIVATIVE COMPRISING SPECIFIC POLAR GROUPS CONSISTING OF HYDROXYL- AND ETHER-FUNCTIONALITIES | L'OREAL (FR) | 2013-01-24 | — | — | WO | disclosed |
| WO-2013010590-A1 | COSMETIC AND/OR DERMATOLOGICAL COMPOSITION CONTAINING A MEROCYANINE DERIVATIVE COMPRISING SPECIFIC POLAR GROUPS CONSISTING OF HYDROXYL- AND ETHER-FUNCTIONALITIES | L'OREAL (FR) | 2013-01-24 | — | — | WO | disclosed |
| CN-102471632-A | Aqueous polymer dispersions as binders for plasters and coatings with improved fire behaviour | BASF SE | 2012-05-23 | — | — | CN | disclosed |
| CN-102325797-A | Binder compositions comprising boric acid or boric acid salt | BASF SE | 2012-01-18 | — | — | CN | disclosed |
| CN-102037034-A | Polymer dispersions containing phosphorous polymers and emulsifiers | BASF SE | 2011-04-27 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11458083-B2 | Cosmetic and/or dermatological composition containing a merocyanine derivative comprising specific polar groups consisting of hydroxyl- and ether-functionalities | KRT18, LAGE3, TYR | ALDH1A1 1018/4885MEN1 621/4885KMT2A 883/4885 |
| US-20140150380-A1 | MEROCYANINE DERIVATIVES | CRY1, MAPRE1, MC5R | ALDH1A1 520/4885MEN1 122/4885KMT2A 2457/4885 |
| US-20140294743-A1 | COSMETIC AND/OR DERMATOLOGICAL COMPOSITION CONTAINING A MEROCYANINE DERIVATIVE COMPRISING SPECIFIC POLAR GROUPS CONSISTING OF HYDROXYL- AND ETHER-FUNCTIONALITIES | KRT18, LAGE3, TYR | ALDH1A1 1018/4885MEN1 621/4885KMT2A 883/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.